Danaher Research and Development Expenses 2010-2024 | DHR
Danaher annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Danaher research and development expenses for the quarter ending December 31, 2024 were $0.442B, a 8.6% increase year-over-year.
- Danaher research and development expenses for the twelve months ending December 31, 2024 were $1.584B, a 5.39% increase year-over-year.
- Danaher annual research and development expenses for 2024 were $1.584B, a 5.39% increase from 2023.
- Danaher annual research and development expenses for 2023 were $1.503B, a 1.64% decline from 2022.
- Danaher annual research and development expenses for 2022 were $1.528B, a 2% increase from 2021.
| Danaher Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,584 |
| 2023 | $1,503 |
| 2022 | $1,528 |
| 2021 | $1,498 |
| 2020 | $1,348 |
| 2019 | $1,126 |
| 2018 | $1,059 |
| 2017 | $956 |
| 2016 | $975 |
| 2015 | $861 |
| 2014 | $769 |
| 2013 | $1,104 |
| 2012 | $1,138 |
| 2011 | $1,019 |
| 2010 | $774 |
| 2009 | $600 |
| Danaher Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $442 |
| 2024-09-30 | $383 |
| 2024-06-30 | $391 |
| 2024-03-31 | $368 |
| 2023-12-31 | $407 |
| 2023-09-30 | $362 |
| 2023-06-30 | $361 |
| 2023-03-31 | $373 |
| 2022-12-31 | $236 |
| 2022-09-30 | $420 |
| 2022-06-30 | $431 |
| 2022-03-31 | $441 |
| 2021-12-31 | $251 |
| 2021-09-30 | $441 |
| 2021-06-30 | $426 |
| 2021-03-31 | $380 |
| 2020-12-31 | $396 |
| 2020-09-30 | $342 |
| 2020-06-30 | $323 |
| 2020-03-31 | $287 |
| 2019-12-31 | $294 |
| 2019-09-30 | $283 |
| 2019-06-30 | $282 |
| 2019-03-31 | $268 |
| 2018-12-31 | $147 |
| 2018-09-30 | $301 |
| 2018-06-30 | $312 |
| 2018-03-31 | $299 |
| 2017-12-31 | $127 |
| 2017-09-30 | $279 |
| 2017-06-30 | $283 |
| 2017-03-31 | $267 |
| 2016-12-31 | $268 |
| 2016-09-30 | $241 |
| 2016-06-30 | $240 |
| 2016-03-31 | $226 |
| 2015-12-31 | $45 |
| 2015-09-30 | $212 |
| 2015-06-30 | $305 |
| 2015-03-31 | $299 |
| 2014-12-31 | $336 |
| 2014-09-30 | $288 |
| 2014-06-30 | $336 |
| 2014-03-31 | $313 |
| 2013-12-31 | $332 |
| 2013-09-30 | $309 |
| 2013-06-30 | $312 |
| 2013-03-31 | $296 |
| 2012-12-31 | $295 |
| 2012-09-30 | $290 |
| 2012-06-30 | $284 |
| 2012-03-31 | $270 |
| 2011-12-31 | $282 |
| 2011-09-30 | $288 |
| 2011-06-30 | $234 |
| 2011-03-31 | $215 |
| 2010-12-31 | $206 |
| 2010-09-30 | $196 |
| 2010-06-30 | $191 |
| 2010-03-31 | $181 |
| 2009-12-31 | $122 |
| 2009-09-30 | $159 |
| 2009-06-30 | $159 |
| 2009-03-31 | $161 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $150.904B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |